nodes	percent_of_prediction	percent_of_DWPC	metapath
Carmustine—Alkylating Activity—Altretamine—ovarian cancer	0.409	0.465	CiPCiCtD
Carmustine—Alkylating Activity—Chlorambucil—ovarian cancer	0.235	0.267	CiPCiCtD
Carmustine—Alkylating Activity—Melphalan—ovarian cancer	0.235	0.267	CiPCiCtD
Carmustine—GSR—Synthesis and interconversion of nucleotide di- and triphosphates—NME2—ovarian cancer	0.00504	0.295	CbGpPWpGaD
Carmustine—GSR—myometrium—ovarian cancer	0.00194	0.118	CbGeAlD
Carmustine—GSR—embryo—ovarian cancer	0.00187	0.113	CbGeAlD
Carmustine—GSR—Nucleotide metabolism—NME2—ovarian cancer	0.00156	0.0912	CbGpPWpGaD
Carmustine—GSR—uterine cervix—ovarian cancer	0.00151	0.0917	CbGeAlD
Carmustine—GSR—decidua—ovarian cancer	0.00144	0.0873	CbGeAlD
Carmustine—GSR—endometrium—ovarian cancer	0.00137	0.0829	CbGeAlD
Carmustine—GSR—gonad—ovarian cancer	0.00127	0.0769	CbGeAlD
Carmustine—GSR—uterus—ovarian cancer	0.00126	0.0764	CbGeAlD
Carmustine—GSR—female reproductive system—ovarian cancer	0.00113	0.0687	CbGeAlD
Carmustine—GSR—bone marrow—ovarian cancer	0.00107	0.0648	CbGeAlD
Carmustine—GSR—female gonad—ovarian cancer	0.00103	0.0625	CbGeAlD
Carmustine—GSR—vagina—ovarian cancer	0.00102	0.0621	CbGeAlD
Carmustine—GSR—testis—ovarian cancer	0.000914	0.0554	CbGeAlD
Carmustine—GSR—Detoxification of Reactive Oxygen Species—SOD1—ovarian cancer	0.000911	0.0533	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—SOD1—ovarian cancer	0.000837	0.049	CbGpPWpGaD
Carmustine—GSR—Detoxification of Reactive Oxygen Species—SOD2—ovarian cancer	0.00082	0.048	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—SOD2—ovarian cancer	0.000754	0.0441	CbGpPWpGaD
Carmustine—GSR—lymph node—ovarian cancer	0.000663	0.0402	CbGeAlD
Carmustine—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—ovarian cancer	0.000485	0.0284	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—SOD1—ovarian cancer	0.000354	0.0207	CbGpPWpGaD
Carmustine—GSR—Nucleotide metabolism—TYMS—ovarian cancer	0.000354	0.0207	CbGpPWpGaD
Carmustine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—ovarian cancer	0.000333	0.0195	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—SOD2—ovarian cancer	0.000319	0.0186	CbGpPWpGaD
Carmustine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—ovarian cancer	0.000303	0.0177	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—SLC5A5—ovarian cancer	0.000286	0.0167	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—SLC2A1—ovarian cancer	0.000276	0.0162	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—HDAC6—ovarian cancer	0.000251	0.0147	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000229	0.0134	CbGpPWpGaD
Carmustine—CYP1A2—Estrogen Receptor Pathway—CYP1B1—ovarian cancer	0.000226	0.0132	CbGpPWpGaD
Carmustine—CYP1A2—Estrogen metabolism—CYP1B1—ovarian cancer	0.000174	0.0102	CbGpPWpGaD
Carmustine—CYP1A2—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000154	0.009	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—SOD1—ovarian cancer	0.000147	0.0086	CbGpPWpGaD
Carmustine—CYP1A2—Estrogen Receptor Pathway—ESR1—ovarian cancer	0.000142	0.00829	CbGpPWpGaD
Carmustine—GSR—Metabolism—NME2—ovarian cancer	0.000142	0.00829	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CCNE1—ovarian cancer	0.000136	0.00794	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—SOD2—ovarian cancer	0.000132	0.00774	CbGpPWpGaD
Carmustine—CYP1A2—Melatonin metabolism and effects—CYP1B1—ovarian cancer	0.000119	0.00695	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—IL6—ovarian cancer	9.75e-05	0.0057	CbGpPWpGaD
Carmustine—GSR—Metabolism—CYTB—ovarian cancer	9.13e-05	0.00534	CbGpPWpGaD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	8.62e-05	0.00504	CbGpPWpGaD
Carmustine—CYP1A2—Tryptophan metabolism—CYP1B1—ovarian cancer	8.21e-05	0.0048	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—ovarian cancer	8.21e-05	0.0048	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—ovarian cancer	8.21e-05	0.0048	CbGpPWpGaD
Carmustine—GSR—Metabolism—BRIP1—ovarian cancer	7.98e-05	0.00467	CbGpPWpGaD
Carmustine—GSR—Metabolism—PPP1CC—ovarian cancer	7.98e-05	0.00467	CbGpPWpGaD
Carmustine—CYP1A2—Estrogen Receptor Pathway—STAT3—ovarian cancer	7.94e-05	0.00464	CbGpPWpGaD
Carmustine—CYP1A2—Arachidonic acid metabolism—CYP1B1—ovarian cancer	7.68e-05	0.00449	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—MTOR—ovarian cancer	7.5e-05	0.00439	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CXCL8—ovarian cancer	7.21e-05	0.00422	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CDKN1B—ovarian cancer	7.04e-05	0.00412	CbGpPWpGaD
Carmustine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	6.64e-05	0.00388	CbGpPWpGaD
Carmustine—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	6.55e-05	0.00383	CbGpPWpGaD
Carmustine—Eye pain—Doxorubicin—ovarian cancer	6.2e-05	0.000711	CcSEcCtD
Carmustine—Diarrhoea—Topotecan—ovarian cancer	6.18e-05	0.00071	CcSEcCtD
Carmustine—Hypoaesthesia—Docetaxel—ovarian cancer	6.17e-05	0.000708	CcSEcCtD
Carmustine—Back pain—Paclitaxel—ovarian cancer	6.16e-05	0.000707	CcSEcCtD
Carmustine—Abdominal pain—Vinorelbine—ovarian cancer	6.11e-05	0.000701	CcSEcCtD
Carmustine—Body temperature increased—Vinorelbine—ovarian cancer	6.11e-05	0.000701	CcSEcCtD
Carmustine—Oedema peripheral—Docetaxel—ovarian cancer	6.11e-05	0.000701	CcSEcCtD
Carmustine—Connective tissue disorder—Docetaxel—ovarian cancer	6.09e-05	0.0007	CcSEcCtD
Carmustine—Hyponatraemia—Epirubicin—ovarian cancer	6.07e-05	0.000697	CcSEcCtD
Carmustine—Diarrhoea—Melphalan—ovarian cancer	6.05e-05	0.000695	CcSEcCtD
Carmustine—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	6.05e-05	0.000694	CcSEcCtD
Carmustine—Diplopia—Epirubicin—ovarian cancer	6.05e-05	0.000694	CcSEcCtD
Carmustine—Nausea—Chlorambucil—ovarian cancer	6.03e-05	0.000692	CcSEcCtD
Carmustine—Vision blurred—Paclitaxel—ovarian cancer	6e-05	0.000689	CcSEcCtD
Carmustine—Visual impairment—Docetaxel—ovarian cancer	5.98e-05	0.000686	CcSEcCtD
Carmustine—Dizziness—Topotecan—ovarian cancer	5.97e-05	0.000686	CcSEcCtD
Carmustine—Tremor—Paclitaxel—ovarian cancer	5.97e-05	0.000685	CcSEcCtD
Carmustine—Anaemia—Paclitaxel—ovarian cancer	5.89e-05	0.000676	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—VEGFA—ovarian cancer	5.86e-05	0.00343	CbGpPWpGaD
Carmustine—Agitation—Paclitaxel—ovarian cancer	5.85e-05	0.000672	CcSEcCtD
Carmustine—Face oedema—Epirubicin—ovarian cancer	5.84e-05	0.00067	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—STAT3—ovarian cancer	5.8e-05	0.00339	CbGpPWpGaD
Carmustine—Eye disorder—Docetaxel—ovarian cancer	5.8e-05	0.000665	CcSEcCtD
Carmustine—Flushing—Docetaxel—ovarian cancer	5.76e-05	0.000661	CcSEcCtD
Carmustine—Vomiting—Topotecan—ovarian cancer	5.74e-05	0.000659	CcSEcCtD
Carmustine—Leukopenia—Paclitaxel—ovarian cancer	5.7e-05	0.000655	CcSEcCtD
Carmustine—Rash—Topotecan—ovarian cancer	5.7e-05	0.000654	CcSEcCtD
Carmustine—Hypersensitivity—Vinorelbine—ovarian cancer	5.69e-05	0.000654	CcSEcCtD
Carmustine—Dermatitis—Topotecan—ovarian cancer	5.69e-05	0.000653	CcSEcCtD
Carmustine—Ataxia—Epirubicin—ovarian cancer	5.69e-05	0.000653	CcSEcCtD
Carmustine—Headache—Topotecan—ovarian cancer	5.66e-05	0.00065	CcSEcCtD
Carmustine—Vomiting—Melphalan—ovarian cancer	5.62e-05	0.000646	CcSEcCtD
Carmustine—Hyponatraemia—Doxorubicin—ovarian cancer	5.62e-05	0.000645	CcSEcCtD
Carmustine—Diplopia—Doxorubicin—ovarian cancer	5.6e-05	0.000642	CcSEcCtD
Carmustine—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	5.6e-05	0.000642	CcSEcCtD
Carmustine—Liver function test abnormal—Epirubicin—ovarian cancer	5.58e-05	0.000641	CcSEcCtD
Carmustine—Rash—Melphalan—ovarian cancer	5.58e-05	0.00064	CcSEcCtD
Carmustine—Dermatitis—Melphalan—ovarian cancer	5.57e-05	0.00064	CcSEcCtD
Carmustine—Asthenia—Vinorelbine—ovarian cancer	5.55e-05	0.000637	CcSEcCtD
Carmustine—Arrhythmia—Docetaxel—ovarian cancer	5.54e-05	0.000636	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—MAPK3—ovarian cancer	5.54e-05	0.00324	CbGpPWpGaD
Carmustine—Convulsion—Paclitaxel—ovarian cancer	5.52e-05	0.000634	CcSEcCtD
Carmustine—Hypokalaemia—Epirubicin—ovarian cancer	5.5e-05	0.000632	CcSEcCtD
Carmustine—Hypertension—Paclitaxel—ovarian cancer	5.5e-05	0.000631	CcSEcCtD
Carmustine—Alopecia—Docetaxel—ovarian cancer	5.48e-05	0.000629	CcSEcCtD
Carmustine—Mental disorder—Docetaxel—ovarian cancer	5.43e-05	0.000624	CcSEcCtD
Carmustine—Chest pain—Paclitaxel—ovarian cancer	5.42e-05	0.000623	CcSEcCtD
Carmustine—Myalgia—Paclitaxel—ovarian cancer	5.42e-05	0.000623	CcSEcCtD
Carmustine—Anxiety—Paclitaxel—ovarian cancer	5.4e-05	0.00062	CcSEcCtD
Carmustine—Face oedema—Doxorubicin—ovarian cancer	5.4e-05	0.00062	CcSEcCtD
Carmustine—Malnutrition—Docetaxel—ovarian cancer	5.4e-05	0.00062	CcSEcCtD
Carmustine—Erythema—Docetaxel—ovarian cancer	5.4e-05	0.00062	CcSEcCtD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	5.38e-05	0.00315	CbGpPWpGaD
Carmustine—Nausea—Topotecan—ovarian cancer	5.37e-05	0.000616	CcSEcCtD
Carmustine—GSR—Metabolism—YAP1—ovarian cancer	5.35e-05	0.00313	CbGpPWpGaD
Carmustine—Muscular weakness—Epirubicin—ovarian cancer	5.33e-05	0.000612	CcSEcCtD
Carmustine—Diarrhoea—Vinorelbine—ovarian cancer	5.29e-05	0.000607	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—MAPK1—ovarian cancer	5.27e-05	0.00308	CbGpPWpGaD
Carmustine—Ataxia—Doxorubicin—ovarian cancer	5.26e-05	0.000604	CcSEcCtD
Carmustine—Nausea—Melphalan—ovarian cancer	5.25e-05	0.000603	CcSEcCtD
Carmustine—Confusional state—Paclitaxel—ovarian cancer	5.24e-05	0.000602	CcSEcCtD
Carmustine—Dysphagia—Epirubicin—ovarian cancer	5.23e-05	0.0006	CcSEcCtD
Carmustine—Back pain—Docetaxel—ovarian cancer	5.22e-05	0.0006	CcSEcCtD
Carmustine—Oedema—Paclitaxel—ovarian cancer	5.2e-05	0.000597	CcSEcCtD
Carmustine—Liver function test abnormal—Doxorubicin—ovarian cancer	5.17e-05	0.000593	CcSEcCtD
Carmustine—Infection—Paclitaxel—ovarian cancer	5.16e-05	0.000593	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—ovarian cancer	5.16e-05	0.00302	CbGpPWpGaD
Carmustine—Dizziness—Vinorelbine—ovarian cancer	5.11e-05	0.000587	CcSEcCtD
Carmustine—Hypokalaemia—Doxorubicin—ovarian cancer	5.09e-05	0.000585	CcSEcCtD
Carmustine—Thrombocytopenia—Paclitaxel—ovarian cancer	5.09e-05	0.000584	CcSEcCtD
Carmustine—Tachycardia—Paclitaxel—ovarian cancer	5.07e-05	0.000582	CcSEcCtD
Carmustine—Anaemia—Docetaxel—ovarian cancer	4.99e-05	0.000573	CcSEcCtD
Carmustine—Pancytopenia—Epirubicin—ovarian cancer	4.96e-05	0.00057	CcSEcCtD
Carmustine—Anorexia—Paclitaxel—ovarian cancer	4.96e-05	0.000569	CcSEcCtD
Carmustine—Muscular weakness—Doxorubicin—ovarian cancer	4.93e-05	0.000567	CcSEcCtD
Carmustine—Vomiting—Vinorelbine—ovarian cancer	4.91e-05	0.000564	CcSEcCtD
Carmustine—Neutropenia—Epirubicin—ovarian cancer	4.89e-05	0.000561	CcSEcCtD
Carmustine—Rash—Vinorelbine—ovarian cancer	4.87e-05	0.000559	CcSEcCtD
Carmustine—Dermatitis—Vinorelbine—ovarian cancer	4.87e-05	0.000559	CcSEcCtD
Carmustine—Hypotension—Paclitaxel—ovarian cancer	4.86e-05	0.000558	CcSEcCtD
Carmustine—Headache—Vinorelbine—ovarian cancer	4.84e-05	0.000556	CcSEcCtD
Carmustine—Dysphagia—Doxorubicin—ovarian cancer	4.84e-05	0.000555	CcSEcCtD
Carmustine—Leukopenia—Docetaxel—ovarian cancer	4.83e-05	0.000555	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	4.74e-05	0.000544	CcSEcCtD
Carmustine—Hyperglycaemia—Epirubicin—ovarian cancer	4.71e-05	0.000541	CcSEcCtD
Carmustine—Insomnia—Paclitaxel—ovarian cancer	4.7e-05	0.00054	CcSEcCtD
Carmustine—Pneumonia—Epirubicin—ovarian cancer	4.69e-05	0.000538	CcSEcCtD
Carmustine—Convulsion—Docetaxel—ovarian cancer	4.68e-05	0.000537	CcSEcCtD
Carmustine—Paraesthesia—Paclitaxel—ovarian cancer	4.67e-05	0.000536	CcSEcCtD
Carmustine—Hypertension—Docetaxel—ovarian cancer	4.66e-05	0.000535	CcSEcCtD
Carmustine—Dyspnoea—Paclitaxel—ovarian cancer	4.63e-05	0.000532	CcSEcCtD
Carmustine—Somnolence—Paclitaxel—ovarian cancer	4.62e-05	0.000531	CcSEcCtD
Carmustine—Chest pain—Docetaxel—ovarian cancer	4.6e-05	0.000528	CcSEcCtD
Carmustine—Myalgia—Docetaxel—ovarian cancer	4.6e-05	0.000528	CcSEcCtD
Carmustine—Pancytopenia—Doxorubicin—ovarian cancer	4.59e-05	0.000527	CcSEcCtD
Carmustine—Nausea—Vinorelbine—ovarian cancer	4.59e-05	0.000527	CcSEcCtD
Carmustine—Renal failure—Epirubicin—ovarian cancer	4.58e-05	0.000526	CcSEcCtD
Carmustine—Neuropathy peripheral—Epirubicin—ovarian cancer	4.57e-05	0.000524	CcSEcCtD
Carmustine—Stomatitis—Epirubicin—ovarian cancer	4.54e-05	0.000521	CcSEcCtD
Carmustine—Urinary tract infection—Epirubicin—ovarian cancer	4.53e-05	0.00052	CcSEcCtD
Carmustine—Neutropenia—Doxorubicin—ovarian cancer	4.52e-05	0.000519	CcSEcCtD
Carmustine—Decreased appetite—Paclitaxel—ovarian cancer	4.52e-05	0.000519	CcSEcCtD
Carmustine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	4.49e-05	0.000515	CcSEcCtD
Carmustine—Constipation—Paclitaxel—ovarian cancer	4.45e-05	0.00051	CcSEcCtD
Carmustine—Pain—Paclitaxel—ovarian cancer	4.45e-05	0.00051	CcSEcCtD
Carmustine—Confusional state—Docetaxel—ovarian cancer	4.44e-05	0.00051	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—TP53—ovarian cancer	4.42e-05	0.00259	CbGpPWpGaD
Carmustine—Oedema—Docetaxel—ovarian cancer	4.41e-05	0.000506	CcSEcCtD
Carmustine—Infection—Docetaxel—ovarian cancer	4.38e-05	0.000503	CcSEcCtD
Carmustine—GSR—Metabolism—FASN—ovarian cancer	4.36e-05	0.00255	CbGpPWpGaD
Carmustine—Hyperglycaemia—Doxorubicin—ovarian cancer	4.36e-05	0.000501	CcSEcCtD
Carmustine—Pneumonia—Doxorubicin—ovarian cancer	4.34e-05	0.000498	CcSEcCtD
Carmustine—Thrombocytopenia—Docetaxel—ovarian cancer	4.31e-05	0.000495	CcSEcCtD
Carmustine—Tachycardia—Docetaxel—ovarian cancer	4.3e-05	0.000494	CcSEcCtD
Carmustine—GSR—Metabolism—SLC5A5—ovarian cancer	4.29e-05	0.00251	CbGpPWpGaD
Carmustine—Feeling abnormal—Paclitaxel—ovarian cancer	4.28e-05	0.000492	CcSEcCtD
Carmustine—Gastrointestinal pain—Paclitaxel—ovarian cancer	4.25e-05	0.000488	CcSEcCtD
Carmustine—Renal failure—Doxorubicin—ovarian cancer	4.24e-05	0.000487	CcSEcCtD
Carmustine—Neuropathy peripheral—Doxorubicin—ovarian cancer	4.23e-05	0.000485	CcSEcCtD
Carmustine—Haemoglobin—Epirubicin—ovarian cancer	4.2e-05	0.000483	CcSEcCtD
Carmustine—Stomatitis—Doxorubicin—ovarian cancer	4.2e-05	0.000482	CcSEcCtD
Carmustine—Anorexia—Docetaxel—ovarian cancer	4.2e-05	0.000482	CcSEcCtD
Carmustine—Urinary tract infection—Doxorubicin—ovarian cancer	4.19e-05	0.000481	CcSEcCtD
Carmustine—Haemorrhage—Epirubicin—ovarian cancer	4.18e-05	0.00048	CcSEcCtD
Carmustine—Hypoaesthesia—Epirubicin—ovarian cancer	4.16e-05	0.000478	CcSEcCtD
Carmustine—GSR—Metabolism—SLC2A1—ovarian cancer	4.15e-05	0.00242	CbGpPWpGaD
Carmustine—Oedema peripheral—Epirubicin—ovarian cancer	4.12e-05	0.000473	CcSEcCtD
Carmustine—Hypotension—Docetaxel—ovarian cancer	4.12e-05	0.000473	CcSEcCtD
Carmustine—Connective tissue disorder—Epirubicin—ovarian cancer	4.11e-05	0.000472	CcSEcCtD
Carmustine—Abdominal pain—Paclitaxel—ovarian cancer	4.11e-05	0.000472	CcSEcCtD
Carmustine—Body temperature increased—Paclitaxel—ovarian cancer	4.11e-05	0.000472	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—IL6—ovarian cancer	4.05e-05	0.00237	CbGpPWpGaD
Carmustine—Visual impairment—Epirubicin—ovarian cancer	4.03e-05	0.000463	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	4.01e-05	0.000461	CcSEcCtD
Carmustine—Insomnia—Docetaxel—ovarian cancer	3.99e-05	0.000458	CcSEcCtD
Carmustine—GSR—Metabolism—CYP1B1—ovarian cancer	3.97e-05	0.00232	CbGpPWpGaD
Carmustine—Paraesthesia—Docetaxel—ovarian cancer	3.96e-05	0.000454	CcSEcCtD
Carmustine—Dyspnoea—Docetaxel—ovarian cancer	3.93e-05	0.000451	CcSEcCtD
Carmustine—Somnolence—Docetaxel—ovarian cancer	3.92e-05	0.00045	CcSEcCtD
Carmustine—Eye disorder—Epirubicin—ovarian cancer	3.91e-05	0.000449	CcSEcCtD
Carmustine—Haemoglobin—Doxorubicin—ovarian cancer	3.89e-05	0.000447	CcSEcCtD
Carmustine—Flushing—Epirubicin—ovarian cancer	3.88e-05	0.000446	CcSEcCtD
Carmustine—Haemorrhage—Doxorubicin—ovarian cancer	3.87e-05	0.000444	CcSEcCtD
Carmustine—Hypoaesthesia—Doxorubicin—ovarian cancer	3.85e-05	0.000442	CcSEcCtD
Carmustine—Decreased appetite—Docetaxel—ovarian cancer	3.83e-05	0.00044	CcSEcCtD
Carmustine—Hypersensitivity—Paclitaxel—ovarian cancer	3.83e-05	0.00044	CcSEcCtD
Carmustine—Oedema peripheral—Doxorubicin—ovarian cancer	3.81e-05	0.000438	CcSEcCtD
Carmustine—Gastrointestinal disorder—Docetaxel—ovarian cancer	3.8e-05	0.000437	CcSEcCtD
Carmustine—Connective tissue disorder—Doxorubicin—ovarian cancer	3.8e-05	0.000437	CcSEcCtD
Carmustine—Pain—Docetaxel—ovarian cancer	3.77e-05	0.000433	CcSEcCtD
Carmustine—Constipation—Docetaxel—ovarian cancer	3.77e-05	0.000433	CcSEcCtD
Carmustine—Arrhythmia—Epirubicin—ovarian cancer	3.74e-05	0.000429	CcSEcCtD
Carmustine—Visual impairment—Doxorubicin—ovarian cancer	3.73e-05	0.000428	CcSEcCtD
Carmustine—Asthenia—Paclitaxel—ovarian cancer	3.73e-05	0.000428	CcSEcCtD
Carmustine—Alopecia—Epirubicin—ovarian cancer	3.7e-05	0.000424	CcSEcCtD
Carmustine—Mental disorder—Epirubicin—ovarian cancer	3.66e-05	0.000421	CcSEcCtD
Carmustine—Malnutrition—Epirubicin—ovarian cancer	3.64e-05	0.000418	CcSEcCtD
Carmustine—Erythema—Epirubicin—ovarian cancer	3.64e-05	0.000418	CcSEcCtD
Carmustine—Feeling abnormal—Docetaxel—ovarian cancer	3.63e-05	0.000417	CcSEcCtD
Carmustine—Eye disorder—Doxorubicin—ovarian cancer	3.62e-05	0.000415	CcSEcCtD
Carmustine—Gastrointestinal pain—Docetaxel—ovarian cancer	3.6e-05	0.000414	CcSEcCtD
Carmustine—Flushing—Doxorubicin—ovarian cancer	3.59e-05	0.000412	CcSEcCtD
Carmustine—Diarrhoea—Paclitaxel—ovarian cancer	3.56e-05	0.000408	CcSEcCtD
Carmustine—GSR—Metabolism—PPP2R1A—ovarian cancer	3.52e-05	0.00206	CbGpPWpGaD
Carmustine—Back pain—Epirubicin—ovarian cancer	3.52e-05	0.000404	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	3.51e-05	0.00205	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	3.51e-05	0.00205	CbGpPWpGaD
Carmustine—Abdominal pain—Docetaxel—ovarian cancer	3.48e-05	0.0004	CcSEcCtD
Carmustine—Body temperature increased—Docetaxel—ovarian cancer	3.48e-05	0.0004	CcSEcCtD
Carmustine—Arrhythmia—Doxorubicin—ovarian cancer	3.46e-05	0.000397	CcSEcCtD
Carmustine—Dizziness—Paclitaxel—ovarian cancer	3.44e-05	0.000395	CcSEcCtD
Carmustine—Vision blurred—Epirubicin—ovarian cancer	3.43e-05	0.000394	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	3.43e-05	0.00201	CbGpPWpGaD
Carmustine—Alopecia—Doxorubicin—ovarian cancer	3.42e-05	0.000393	CcSEcCtD
Carmustine—Mental disorder—Doxorubicin—ovarian cancer	3.39e-05	0.000389	CcSEcCtD
Carmustine—Erythema—Doxorubicin—ovarian cancer	3.37e-05	0.000387	CcSEcCtD
Carmustine—Malnutrition—Doxorubicin—ovarian cancer	3.37e-05	0.000387	CcSEcCtD
Carmustine—Anaemia—Epirubicin—ovarian cancer	3.37e-05	0.000386	CcSEcCtD
Carmustine—Agitation—Epirubicin—ovarian cancer	3.35e-05	0.000384	CcSEcCtD
Carmustine—Vomiting—Paclitaxel—ovarian cancer	3.31e-05	0.000379	CcSEcCtD
Carmustine—Rash—Paclitaxel—ovarian cancer	3.28e-05	0.000376	CcSEcCtD
Carmustine—Dermatitis—Paclitaxel—ovarian cancer	3.27e-05	0.000376	CcSEcCtD
Carmustine—GSR—Metabolism—ABCB1—ovarian cancer	3.27e-05	0.00191	CbGpPWpGaD
Carmustine—Leukopenia—Epirubicin—ovarian cancer	3.26e-05	0.000374	CcSEcCtD
Carmustine—Back pain—Doxorubicin—ovarian cancer	3.26e-05	0.000374	CcSEcCtD
Carmustine—Headache—Paclitaxel—ovarian cancer	3.26e-05	0.000374	CcSEcCtD
Carmustine—Hypersensitivity—Docetaxel—ovarian cancer	3.25e-05	0.000373	CcSEcCtD
Carmustine—GSR—Metabolism—TYMS—ovarian cancer	3.21e-05	0.00188	CbGpPWpGaD
Carmustine—Vision blurred—Doxorubicin—ovarian cancer	3.18e-05	0.000365	CcSEcCtD
Carmustine—Asthenia—Docetaxel—ovarian cancer	3.16e-05	0.000363	CcSEcCtD
Carmustine—Convulsion—Epirubicin—ovarian cancer	3.16e-05	0.000362	CcSEcCtD
Carmustine—Hypertension—Epirubicin—ovarian cancer	3.14e-05	0.000361	CcSEcCtD
Carmustine—Anaemia—Doxorubicin—ovarian cancer	3.11e-05	0.000358	CcSEcCtD
Carmustine—Myalgia—Epirubicin—ovarian cancer	3.1e-05	0.000356	CcSEcCtD
Carmustine—Chest pain—Epirubicin—ovarian cancer	3.1e-05	0.000356	CcSEcCtD
Carmustine—Agitation—Doxorubicin—ovarian cancer	3.1e-05	0.000355	CcSEcCtD
Carmustine—Anxiety—Epirubicin—ovarian cancer	3.09e-05	0.000355	CcSEcCtD
Carmustine—Nausea—Paclitaxel—ovarian cancer	3.09e-05	0.000354	CcSEcCtD
Carmustine—Leukopenia—Doxorubicin—ovarian cancer	3.02e-05	0.000346	CcSEcCtD
Carmustine—Diarrhoea—Docetaxel—ovarian cancer	3.01e-05	0.000346	CcSEcCtD
Carmustine—Confusional state—Epirubicin—ovarian cancer	3e-05	0.000344	CcSEcCtD
Carmustine—Oedema—Epirubicin—ovarian cancer	2.97e-05	0.000341	CcSEcCtD
Carmustine—Infection—Epirubicin—ovarian cancer	2.95e-05	0.000339	CcSEcCtD
Carmustine—Convulsion—Doxorubicin—ovarian cancer	2.92e-05	0.000335	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	2.92e-05	0.00171	CbGpPWpGaD
Carmustine—Dizziness—Docetaxel—ovarian cancer	2.91e-05	0.000335	CcSEcCtD
Carmustine—Thrombocytopenia—Epirubicin—ovarian cancer	2.91e-05	0.000334	CcSEcCtD
Carmustine—Hypertension—Doxorubicin—ovarian cancer	2.91e-05	0.000334	CcSEcCtD
Carmustine—Tachycardia—Epirubicin—ovarian cancer	2.9e-05	0.000333	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	2.88e-05	0.00168	CbGpPWpGaD
Carmustine—Chest pain—Doxorubicin—ovarian cancer	2.87e-05	0.000329	CcSEcCtD
Carmustine—Myalgia—Doxorubicin—ovarian cancer	2.87e-05	0.000329	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	2.86e-05	0.00167	CbGpPWpGaD
Carmustine—Anxiety—Doxorubicin—ovarian cancer	2.86e-05	0.000328	CcSEcCtD
Carmustine—Anorexia—Epirubicin—ovarian cancer	2.83e-05	0.000325	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	2.82e-05	0.00165	CbGpPWpGaD
Carmustine—Vomiting—Docetaxel—ovarian cancer	2.8e-05	0.000322	CcSEcCtD
Carmustine—Rash—Docetaxel—ovarian cancer	2.78e-05	0.000319	CcSEcCtD
Carmustine—Hypotension—Epirubicin—ovarian cancer	2.78e-05	0.000319	CcSEcCtD
Carmustine—Dermatitis—Docetaxel—ovarian cancer	2.78e-05	0.000319	CcSEcCtD
Carmustine—Confusional state—Doxorubicin—ovarian cancer	2.77e-05	0.000318	CcSEcCtD
Carmustine—Headache—Docetaxel—ovarian cancer	2.76e-05	0.000317	CcSEcCtD
Carmustine—Oedema—Doxorubicin—ovarian cancer	2.75e-05	0.000316	CcSEcCtD
Carmustine—Infection—Doxorubicin—ovarian cancer	2.73e-05	0.000314	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	2.71e-05	0.000311	CcSEcCtD
Carmustine—Thrombocytopenia—Doxorubicin—ovarian cancer	2.69e-05	0.000309	CcSEcCtD
Carmustine—Insomnia—Epirubicin—ovarian cancer	2.69e-05	0.000309	CcSEcCtD
Carmustine—Tachycardia—Doxorubicin—ovarian cancer	2.68e-05	0.000308	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	2.68e-05	0.00157	CbGpPWpGaD
Carmustine—Paraesthesia—Epirubicin—ovarian cancer	2.67e-05	0.000306	CcSEcCtD
Carmustine—Dyspnoea—Epirubicin—ovarian cancer	2.65e-05	0.000304	CcSEcCtD
Carmustine—Somnolence—Epirubicin—ovarian cancer	2.64e-05	0.000303	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	2.62e-05	0.00154	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	2.62e-05	0.00154	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	2.62e-05	0.00154	CbGpPWpGaD
Carmustine—Anorexia—Doxorubicin—ovarian cancer	2.62e-05	0.000301	CcSEcCtD
Carmustine—Nausea—Docetaxel—ovarian cancer	2.62e-05	0.0003	CcSEcCtD
Carmustine—GSR—Metabolism—CAV1—ovarian cancer	2.59e-05	0.00151	CbGpPWpGaD
Carmustine—Decreased appetite—Epirubicin—ovarian cancer	2.58e-05	0.000297	CcSEcCtD
Carmustine—Hypotension—Doxorubicin—ovarian cancer	2.57e-05	0.000295	CcSEcCtD
Carmustine—Gastrointestinal disorder—Epirubicin—ovarian cancer	2.57e-05	0.000295	CcSEcCtD
Carmustine—Pain—Epirubicin—ovarian cancer	2.54e-05	0.000292	CcSEcCtD
Carmustine—Constipation—Epirubicin—ovarian cancer	2.54e-05	0.000292	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	2.51e-05	0.000288	CcSEcCtD
Carmustine—Insomnia—Doxorubicin—ovarian cancer	2.49e-05	0.000286	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	2.48e-05	0.00145	CbGpPWpGaD
Carmustine—Paraesthesia—Doxorubicin—ovarian cancer	2.47e-05	0.000283	CcSEcCtD
Carmustine—Dyspnoea—Doxorubicin—ovarian cancer	2.45e-05	0.000281	CcSEcCtD
Carmustine—Feeling abnormal—Epirubicin—ovarian cancer	2.45e-05	0.000281	CcSEcCtD
Carmustine—Somnolence—Doxorubicin—ovarian cancer	2.44e-05	0.000281	CcSEcCtD
Carmustine—Gastrointestinal pain—Epirubicin—ovarian cancer	2.43e-05	0.000279	CcSEcCtD
Carmustine—Decreased appetite—Doxorubicin—ovarian cancer	2.39e-05	0.000274	CcSEcCtD
Carmustine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	2.37e-05	0.000273	CcSEcCtD
Carmustine—GSR—Metabolism—PIK3CG—ovarian cancer	2.36e-05	0.00138	CbGpPWpGaD
Carmustine—Constipation—Doxorubicin—ovarian cancer	2.35e-05	0.00027	CcSEcCtD
Carmustine—Pain—Doxorubicin—ovarian cancer	2.35e-05	0.00027	CcSEcCtD
Carmustine—Abdominal pain—Epirubicin—ovarian cancer	2.35e-05	0.00027	CcSEcCtD
Carmustine—Body temperature increased—Epirubicin—ovarian cancer	2.35e-05	0.00027	CcSEcCtD
Carmustine—Feeling abnormal—Doxorubicin—ovarian cancer	2.27e-05	0.00026	CcSEcCtD
Carmustine—Gastrointestinal pain—Doxorubicin—ovarian cancer	2.25e-05	0.000258	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	2.21e-05	0.00129	CbGpPWpGaD
Carmustine—Hypersensitivity—Epirubicin—ovarian cancer	2.19e-05	0.000251	CcSEcCtD
Carmustine—Body temperature increased—Doxorubicin—ovarian cancer	2.17e-05	0.00025	CcSEcCtD
Carmustine—Abdominal pain—Doxorubicin—ovarian cancer	2.17e-05	0.00025	CcSEcCtD
Carmustine—Asthenia—Epirubicin—ovarian cancer	2.13e-05	0.000245	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	2.11e-05	0.00123	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CD—ovarian cancer	2.07e-05	0.00121	CbGpPWpGaD
Carmustine—Diarrhoea—Epirubicin—ovarian cancer	2.03e-05	0.000233	CcSEcCtD
Carmustine—Hypersensitivity—Doxorubicin—ovarian cancer	2.03e-05	0.000233	CcSEcCtD
Carmustine—Asthenia—Doxorubicin—ovarian cancer	1.97e-05	0.000227	CcSEcCtD
Carmustine—Dizziness—Epirubicin—ovarian cancer	1.97e-05	0.000226	CcSEcCtD
Carmustine—Vomiting—Epirubicin—ovarian cancer	1.89e-05	0.000217	CcSEcCtD
Carmustine—Diarrhoea—Doxorubicin—ovarian cancer	1.88e-05	0.000216	CcSEcCtD
Carmustine—Rash—Epirubicin—ovarian cancer	1.87e-05	0.000215	CcSEcCtD
Carmustine—Dermatitis—Epirubicin—ovarian cancer	1.87e-05	0.000215	CcSEcCtD
Carmustine—Headache—Epirubicin—ovarian cancer	1.86e-05	0.000214	CcSEcCtD
Carmustine—Dizziness—Doxorubicin—ovarian cancer	1.82e-05	0.000209	CcSEcCtD
Carmustine—GSR—Metabolism—PIK3CB—ovarian cancer	1.81e-05	0.00106	CbGpPWpGaD
Carmustine—Nausea—Epirubicin—ovarian cancer	1.77e-05	0.000203	CcSEcCtD
Carmustine—Vomiting—Doxorubicin—ovarian cancer	1.75e-05	0.000201	CcSEcCtD
Carmustine—CYP1A2—Metabolism—NME2—ovarian cancer	1.74e-05	0.00102	CbGpPWpGaD
Carmustine—Rash—Doxorubicin—ovarian cancer	1.73e-05	0.000199	CcSEcCtD
Carmustine—Dermatitis—Doxorubicin—ovarian cancer	1.73e-05	0.000199	CcSEcCtD
Carmustine—Headache—Doxorubicin—ovarian cancer	1.72e-05	0.000198	CcSEcCtD
Carmustine—Nausea—Doxorubicin—ovarian cancer	1.63e-05	0.000188	CcSEcCtD
Carmustine—GSR—Metabolism—PTEN—ovarian cancer	1.56e-05	0.000914	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.48e-05	0.000865	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.21e-05	0.000705	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYTB—ovarian cancer	1.12e-05	0.000657	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CA—ovarian cancer	1.1e-05	0.000645	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.1e-05	0.000642	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PPP1CC—ovarian cancer	9.82e-06	0.000574	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—BRIP1—ovarian cancer	9.82e-06	0.000574	CbGpPWpGaD
Carmustine—GSR—Metabolism—AKT1—ovarian cancer	9e-06	0.000527	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	7.16e-06	0.000419	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—YAP1—ovarian cancer	6.59e-06	0.000385	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.52e-06	0.000381	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.73e-06	0.000335	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—FASN—ovarian cancer	5.37e-06	0.000314	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SLC5A5—ovarian cancer	5.28e-06	0.000309	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SLC2A1—ovarian cancer	5.1e-06	0.000298	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5e-06	0.000292	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP1B1—ovarian cancer	4.89e-06	0.000286	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	4.34e-06	0.000254	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.32e-06	0.000252	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ABCB1—ovarian cancer	4.03e-06	0.000236	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—TYMS—ovarian cancer	3.96e-06	0.000231	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CAV1—ovarian cancer	3.19e-06	0.000186	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.05e-06	0.000178	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CG—ovarian cancer	2.9e-06	0.00017	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CD—ovarian cancer	2.55e-06	0.000149	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CB—ovarian cancer	2.22e-06	0.00013	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PTEN—ovarian cancer	1.92e-06	0.000112	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.36e-06	7.93e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—AKT1—ovarian cancer	1.11e-06	6.48e-05	CbGpPWpGaD
